Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 30, 2012

View Archived Issues

U.S. university researchers disclose novel beta-amyloid production inhibitors

Pierre Fabre discloses new monoclonal antibodies for cancer

Novartis reflects on accomplishments of 2011

Novel phosphodiesterase 10A inhibitors prepared by Lundbeck

Merck KGaA patents new TGF-beta receptor type-1 inhibitors

Janssen Pharmaceutica synthesizes novel beta-secretase 1 inhibitors

Scientists at Cellzome patent novel TYK2 inhibitors

Histone deacetylase inhibitors may have potential in treating Gaucher's disease

Experiments delineate antiseizure activity of valpromide homolog

GenVec extends licensing and collaboration agreement with Novartis

Swissmedic grants marketing authorization for transdermal estradiol spray

Amgen enters definitive merger agreement

Cancer Research UK begins study of AT-9283

Indication for Gadovist 1.0 is expanded

FDA accepts bosutinib NDA for review

Infinity Pharmaceuticals completes preliminary analysis of saridegib/gemcitabine combination study

FDA approves axitinib for advanced renal cell carcinoma

Cell Therapeutics withdraws Pixuvri NDA

FDA approves first-ever once-weekly treatment for type 2 diabetes

European Commission requests further information in Glybera review

IDMC reviews Ziopharm's study of palifosfamide in metastatic soft tissue sarcoma

Amgen offers pipeline update for 2011

MT-110 shows promise in models of pancreatic cancer

Overseas trials begin for Pro-Rvlysin prostate cancer treatment

Navidea Biopharmaceuticals enters into agreement for Parkinson's disease imaging agent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...